1. The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model
   Jinjiao He et al, 2021, Journal of Medical Virology CrossRef
2. Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance
   Weike Li et al, 2019, Molecular Therapy - Oncolytics CrossRef
3. Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
   Wenhao Luo et al, 2022, Cancer Cell International CrossRef
4. Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
   A-Rum Yoon et al, 2023, Cancer Letters CrossRef
5. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
   Maryum Nisar et al, 2022, Frontiers in Oncology CrossRef
6. Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy
   Victoria Heather Gilchrist et al, 2020, Cytokine & Growth Factor Reviews CrossRef
7. The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them
   Pei-Yang Hu et al, 2020, Applied Microbiology and Biotechnology CrossRef
8. Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus
   Hangxiang Gao et al, 2019, Technology in Cancer Research & Treatment CrossRef
9. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer
   María del Mar Noblejas-López et al, 2022, International Journal of Molecular Sciences CrossRef
10. TRAIL-based gene delivery and therapeutic strategies
    Hui-hai Zhong et al, 2019, Acta Pharmacologica Sinica CrossRef
11. Dose and drug changes in chronic lymphocytic leukemia cell response in�vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors
    Małgorzata Kubczak et al, 2019, Molecular Medicine Reports CrossRef